Trividia Health, Inc., announced today that it's TRUE METRIX (R) Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the ...

Trividia Health, Inc., announced today that it’s TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the ...

CVS Health CVS and Fresenius Medical Care AG & Co.FMS are two major players in the healthcare services sector, but with distinct areas of focus. CVS Health is a leading health solutions company ...

One of the nation’s most powerful pharmacy intermediaries is quietly charging the military’s health insurance program $484 ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Pricing issues have taken precedence as CVS Health’s (NYSE:CVS) pharmacy benefit manager, CVS Caremark, continues to hold off adding Yeztugo, Gilead Sciences’ (NASDAQ:GILD) new HIV prevention drug, to ...

Philadelphia has sued major pharmacy benefit managers, alleging their marketing and distribution of opioids contributed to ...

A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more? CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...

Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for ...

CVS Health Corporation CVS posted third-quarter 2025 adjusted earnings per share (EPS) of $1.60, up 46.8% year over year. The metric topped the Zacks Consensus Estimate by 17.65%. The adjusted EPS ...

That's great news not just for Maronan, but for a stable of ASX companies, with long-term shareholder Red Metal (ASX:RDM) saying the PEA has defined a clear line of site towards development and is ...